Ozempic Patent Expiry Set to Spark Cheaper Weight-Loss Drug Boom in India
The patent for semaglutide the key ingredient in Ozempic and Wegovy developed by Novo Nordisk is set to expire in…
Tata 1MG
Read More
June 18, 2026
- WB Asks Private Hospitals to Reserve 10% Beds for Free Treatment
- Novartis India introduces Pluvicto, Country’s First Approved Radioligand Therapy for Advanced Prostate Cancer
- Private Hospitals in India Lag Behind in Medical Research, Study Reveals
- India Restricts Over-the-Counter Sale of Cough Syrups; Prescriptions Now Mandatory